Work

Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled Trial

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-24-2531

Authors: Chunmeng Wang, Xianglin Hu, Lingge Yang, Yu Xu, Biqiang Zheng, Jilong Yang, Zhichao Liao, Zhengwang Sun, Shengjian Zhang, Lin Yu, Yan Yan, Yong Chen, Tomohiro Fujiwara, Jianrong Zhang, Ilia N. Buhtoiarov, Yangbai Sun, Wangjun Yan

Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Hunan Normal University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Okayama University, The University of Melbourne, Victorian Comprehensive Cancer Centre, Cleveland Clinic

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407253296

FWCI: 5.338

Cites: 47

Cited by: 9

Related to: 10